There are 2934 resources available
EONS - Introducing palliative care in Estonia: How the RECaN project is facilitating the process?
Presenter: Kristina Karp
Session: EONS 12: Recent trends in palliative care
Resources:
Slides
Webcast
4379 - Results of a phase I trial with MART-1 T cell receptor modified T cells in patients with metastatic melanoma
Presenter: Maartje Rohaan
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
3770 - Parallel comparison of 4-1BB or CD28 co-stimulated CD19-targeted chimeric antigen receptor-T cells for B-cell non-Hodgkin lymphoma
Presenter: Zhitao Ying
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
2096 - Clinical study of personalized neoantigen peptide vaccination in advanced NSCLC patients
Presenter: Xueming Du
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
2234 - A phase 1 trial of GEN-009, a neoantigen vaccine using ATLAS™, an autologous immune assay, to identify immunogenic and inhibitory tumor mutations.
Presenter: Przemyslaw Twardowski
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
1523 - Natural dendritic cell vaccinations generate immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Presenter: Jeroen Creemers
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
1460 - Active immunization with immune checkpoint inhibitors-mimotope elicits strong anti-tumor effect against Her-2/neu-expressing tumors
Presenter: Joshua Tobias
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
2682 - Personal Antigen Selection Calculator (PASCal) for the design of personal cancer vaccines
Presenter: Eszter Somogyi
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
4157 - A novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumor responses in synovial sarcoma patients
Presenter: Hiroyoshi Hattori
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
4739 - Adoptive T cell therapy with TBI-1301 results in gene-engineered T cell persistence and anti-tumor responses in patients with NY-ESO-1 expressing solid tumors.
Presenter: Marcus Butler
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract